Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × OTHER_GOV × Gene Expression × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 1

Interventions

pembrolizumab 9 Drug Therapy 9 Cyclophosphamide 8 Carboplatin 8 Bevacizumab 8 Radiotherapy 7 Surgical Procedures, Operative 6 Docetaxel 6 Capecitabine 6 tislelizumab 5 Paclitaxel 5 Oxaliplatin 5 Nivolumab 5 fludarabine 4 Immune Checkpoint Inhibitors 4 Gemcitabine 4 Fluorouracil 4 Endoscopic Mucosal Resection 4 Control Groups 4 Cisplatin 4 pegylated granulocyte colony-stimulating factor 3 Trastuzumab 3 Neoadjuvant Therapy 3 Laparoscopy 3 Irinotecan 3 Injections 3 HMPL-013 3 Granulocyte Colony-Stimulating Factor 3 Etoposide 3 Cytarabine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07169396 2025-09-11

GEN_EXP_CO2021

Azienda USL Reggio Emilia - IRCCS

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡